Article
SULT and UGT Genetic Variants Modulate Side Effect Profiles in South African Breast Cancer Patients Treated with Tamoxifen.
Genes - 24 Feb 2026
Kruger Bianca, Chimusa Emile, Abera Aron, Singh Jesmika, Shamley Delva, Dandara Collet
Abstract excerpt
Background: Tamoxifen remains the cornerstone of endocrine therapy for hormone receptor-positive breast cancer across Africa. Understanding the factors that influence tamoxifen tolerability is critical, as treatment-related side effects can reduce adherence and compromise therapeutic outcomes. Yet, the contribution of pharmacogenetic variation to tamoxifen-related toxicity remains poorly characterized in African...
Topics
- Adult
- Female
- Humans
- Middle Aged
- Antineoplastic Agents, Hormonal
- Arylsulfotransferase
- Breast Neoplasms
- Drug-Related Side Effects and Adverse Reactions
- Glucuronosyltransferase
- Polymorphism, Single Nucleotide
